S&P 500
5,928.27
-0.6%
-35.33
DJI
42,587.72
-0.5%
-204.35
NASDAQ
$19,116.09
-0.5%
-$99.37
Bitcoin
106,278.00
+0.9%
+954.42
AAPL
$205.97
-1.3%
-$2.81
AMZN
$203.45
-1.3%
-$2.71
GOOG
$165.98
-1.1%
-$1.89
META
$634.96
-0.9%
-$5.47
MSFT
$455.94
-0.6%
-$2.93
NVDA
$133.73
-1.4%
-$1.84
TSLA
$352.59
+3.1%
+$10.50
Opiant Pharmaceuticals (NASDAQ: OPNT)
Some price data may be temporarily unavailable.
Opiant Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Opiant Pharmaceuticals Company Info
Opiant Pharmaceuticals is a pharmaceutical company that develops treatments for drug overdose and addictions leveraging intranasal and injectable delivery technologies. The company, formerly known as Lightlake Therapeutics, was founded in 2009, has a team of addiction experts, and is headquartered in Santa Monica, California.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.